| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |